Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Foreign Regulator Exchange Program Contemplated By U.S. State Department

16 Jan 2012

• By Derrick Gingery

Related Content

First FDA Center Of Excellence For Regulatory Science Looks At Nanotechnology

15 Aug 2011

Good Neighbors Make Good Regulatory Science Centers, FDA Decides

28 Nov 2011

Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions

23 Apr 2010

Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections

07 Dec 2011

FDA Foreign Inspections User Fee Program Getting Push On The Hill

04 Jul 2011

Additional Topics

United States China Asia Pacific Legal Issues Compliance Manufacturing BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.